Novel antimicrobial peptides and methods of use thereof
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antimicrobial peptides (AMPs) face challenges such as short half-life, susceptibility to protease degradation, and cytotoxicity to host cells, limiting their effectiveness against antibiotic-resistant bacteria.
Innovation Solution
Development of a synthetic antimicrobial peptide (AMP) with a sequence that exhibits at least 85% identity with SEQ ID NO:1, formulated in a nanoparticle formulation, particularly using graphene nanofibers, to enhance stability and target specificity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If natural antimicrobial peptides are used against antibiotic-resistant bacteria, then antibacterial activity is achieved, but half-life is short and susceptibility to protease degradation occurs
Solution Approach 1:
The patent applies composite materials by combining the antimicrobial peptide with a polymer backbone to create a hybrid molecule. The polymer provides structural stability and resistance to protease degradation, while the peptide moiety retains antibacterial activity. This composite approach resolves the contradiction by maintaining reliability through the active peptide component while extending duration of action through the stable polymer framework.
Solution Approach 2:
The patent employs parameter changes by modifying the physical and chemical properties of the peptide through conjugation with polymer chains. This changes the molecular weight, hydrophilicity, and structural rigidity parameters, thereby protecting the peptide from rapid degradation by proteases while preserving its ability to interact with bacterial targets.
2Reliability
If natural antimicrobial peptides are used against antibiotic-resistant bacteria, then antibacterial activity is achieved, but cytotoxicity to host cells occurs
Solution Approach 1:
The patent applies local quality by creating asymmetric structures where different regions of the molecule have distinct functions. The polymer portion provides stability and reduced toxicity, while the localized peptide region maintains antibacterial activity. This spatial differentiation allows the molecule to selectively target bacteria while minimizing harm to host cells, resolving the contradiction between effectiveness and safety.
3Reliability
If currently employed antibiotics are used, then treatment of bacterial infections is achieved, but antibiotic resistance develops
Solution Approach 1:
The patent employs copying by creating synthetic analogs of natural antimicrobial peptides with modified structures that replicate the essential antibacterial functions while evading bacterial resistance mechanisms. The polymer-peptide conjugates mimic the action of natural AMPs but with enhanced stability and altered recognition profiles, allowing them to overcome resistance developed against conventional antibiotics.
Data Source
AI summary
A composition comprising a peptide comprising a sequence that has at least 85% identity with the amino acid sequence set forth in SEQ ID NO:1. Also provided is a method of treating or preventing a disease comprising administering a pharmaceutical composition comprising an therapeutically effective amount of the peptide.